Showing 1151-1160 of 1634 results for "".
- Exosome Update: ELEVAI Labs Announces Pricing of $6,000,000 IPOhttps://modernaesthetics.com/news/exosome-update-elevai-labs-announces-pricing-of-6000000-ipo/2473530/Elevai Labs, Inc. announced the pricing of its initial public offering. The Offering consists of 1,500,000 shares of common stock at a public offering price of $4.00 per share, for total gross proceeds of $6,000,000 before deducting underwriting discounts and o
- Avéli Cellulite Device Cleared in Australiahttps://modernaesthetics.com/news/aveli-cellulite-device-cleared-in-australia/2473527/Revelle Aesthetics’ Avéli is now cleared for long-term reduction in the appearance of cellulite in Austr
- Natrelle Unveils New "For Every BODY" Campaignhttps://modernaesthetics.com/news/natrelle-unveils-new-for-every-body-campaign/2473519/Allergan Aesthetics’ is launching "For Every BODY," a new Natrelle campaign that showcases how the Natrelle breast implant portfolio can provide a customized look for every body. "Our mar
- Revision Skincare Unveils New "The Science Is Black and White" Brand Campaignhttps://modernaesthetics.com/news/revision-skincare-unveils-new-the-science-is-black-and-white-brand-campaign/2473507/Revision Skincare is rolling out its new brand campaign: "The Science Is Black and White." The campaign, which emphasizes that there are no gray areas when it comes to results, speaks to both consumers and skincare providers. Revision Skincare will be cel
- Hair Relaxers Linked to Uterine Cancer in Black Womenhttps://modernaesthetics.com/news/hair-relaxers-linked-to-uterine-cancer-in-black-women/2473506/Long-term use of chemical hair relaxers by postmenopausal Black women may increase risk of uterine cancer, according to a new study by researchers at Boston University’s Black Women’s Health Study (BWHS). These products contain potentially harmful ingredients, including chem
- Dr. Ashley Brissette Is Clinique’s First Guiding Ophthalmologisthttps://modernaesthetics.com/news/nyc-ophthalmologist-dr-ashley-brissette-is-cliniques-first-guiding-ophthalmologist/2473481/NYC-based ophthalmologist Ashley Brissette, MD, MSc, FRCSC, is Clinique’s first guiding ophthalmologist. In the newly created role, Dr. Brissette will help educate consumers on the importance of eye safety, help guide the development of new products, and contribute to C
- Study: Belotero Balance (+) Restores Volume to Under-eye Hollowshttps://modernaesthetics.com/news/study-belotero-balance-restores-volume-to-under-eye-hollows/2473429/Belotero Balance® (+) corrects volume loss in the infraorbital hollow area, according to new data from Merz Aesthetics. Merz Aesthetics will submit these data as part of a supplemental Premarket Approval Application (sPMA) with the U.S. Food and Drug Administration (FDA) this
- FDA Approves Galderma's Restylane Eyelighthttps://modernaesthetics.com/news/fda-approves-galdermas-restylane-eyelight/2473423/The U.S. Food and Drug Administration (FDA) approved Restylane Eyelight, a hyaluronic acid (HA) dermal filler for the correction of undereye hollowing, in adults over the age of 21. Restylane Eyelight is formulated with NASHA Technology, which has a firm gel te
- Analysis: Millennials Drive Spending Growth in a Post-COVID Aesthetics Industryhttps://modernaesthetics.com/news/analysis-millennials-drive-spending-growth-in-a-post-covid-aesthetics-industry/2473413/The aesthetics industry is undergoing a swift transformation. Analysis of data from the last 5 years paints a clear picture of a post-pandemic shift in how the industry is addressing changing demand and the needs of a rapidly evolving customer base, according to market intelligence prov
- Filler Fatigue: Galderma Survey Separates Fact from Fictionhttps://modernaesthetics.com/news/filler-fatigue-galderma-survey-separates-fact-from-fiction/2473395/Forty percent of people say they would discourage others from using facial injectables to reduce wrinkles or provide volume, and 34% said they believed the results of such treatments look fake and unnatural, according to a new poll sponsored by Galderma. Despite these views, the same re